New York, 01/07/2025 / 13:46, EST/EDT – EQS Newswire – Laxxon Medical Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals,
EQS-News: QUANTRO Therapeutics GmbH / Key word(s): Conference/Research Update QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening 07.01.2025 /
Issuer: Immunic AG / Key word(s): Miscellaneous 07.01.2025 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Highlights 2024
EQS-News: Pentixapharm Holding AG / Key word(s): Agreement Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope 07.01.2025 / 10:30 CET/CEST The
Kuros Biosciences AG / Key word(s): Agreement 07-Jan-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is